Experts Say Proposal for Value-Based Pricing of Antimicrobials “Has Potential”

“‘The PAVE award is an interesting and encouraging proposal geared toward shifting reimbursement towards value-based metrics,’ said Matrix Global Advisors founder and CEO Alex Brill. ‘This proposal might be further strengthened if in addition to the ‘carrot’ for improved reimbursement models for new products, a ‘stick’ to discourage inappropriate over-utilization of existing products was also included.'”